Zamknij X

INFORMACJA DOTYCZĄCA PLIKÓW COOKIES:

Ten serwis stosuje pliki cookies. Korzystanie z witryny bez zmiany ustawień Twojej przeglądarki oznacza, że będą one umieszczane w Twoim urządzeniu końcowym. Pamiętaj, że zawsze możesz zmienić te ustawienia.

  • A
  • A
  • A

Workshop on the SPC Manufacturing Waiver

2018-02-21

Boosting jobs, growth, competitiveness and consumer rights in Europe
through the Supplementary Protection Certificate Manufacturing Waiver

Brussels, 21st February 2018
10h00-12h00
Room 6Q1, European Parliament


WELCOME ADDRESS
10h00

Elżbieta Łukacijewska, EPP Member of the European Parliament (ENVI Committee)
Tadeusz Zwiefka, EPP Member of the European Parliament (JURI Committee)

Introductory remarks
Amaryllis Verhoeven, Head of Unit, Intellectual Property and the Fight against Counterfeiting,
European Commision

Introduction to the panel
The role of the SPC Manufacturing waiver in the Polish economy
10h20
Grzegorz Rychwalski, Polish Union of Employers in Pharmaceutical Industry, Polish Confederation Lewiatan

PANEL DEBATE
Potential impact of the SPC Manufacturing Waiver on patients, jobs, SMEs and the European economy

Moderator of the session:
▪ Adrian van den Hoven, Director General Medicines for Europe
Panel discussion:
▪ Szymon Chrostowski, Polish Coalition of Oncologic patients
▪ Rajmund Ireneusz Martyniuk, Vice President of the Management Board Polpharma Group
▪ Victor Lino Mendonça, Head of Policy & Market Access, Europe for Mylan
▪ Adrian Niewęgłowski, IP Law expert, PhD, Maria Curie, Sklodowska University

DISCUSSION (Q&A)

CONCLUSIONS by the moderator
11h45
Adrian van den Hoven, Director General Medicines for Europe

End of works - 12h00